Jiangsu Hualv Biological Technology Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 294.65 million compared to CNY 241.55 million a year ago. Revenue was CNY 294.65 million compared to CNY 241.56 million a year ago.

Net income was CNY 0.323577 million compared to CNY 0.062073 million a year ago. Basic earnings per share from continuing operations was CNY 0.0028 compared to CNY 0.0005 a year ago. Diluted earnings per share from continuing operations was CNY 0.0028 compared to CNY 0.0005 a year ago.